Keystone Heart Ltd. is a medical device company developing and manufacturing embolic cerebral protection devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures.
The Company is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, surgical valve replacement, atrial fibrillation ablation and other cardiovascular procedures. The novel TriGuard™ product pipeline is designed to help interventional cardiologists, electrophysiologists and cardiac surgeons to preserve brain reserve while performing these procedures.
Headquartered in Israel, with US operations in Tampa, FL, Keystone Heart is dedicated to advancing patient care through innovative technology and clinical research. The Company’s management has extensive experience in the fields of interventional cardiology and medical devices.
|Employees (est.) (Feb 2020)||31||(+11%)|
Keystone Heart total Funding
Keystone Heart latest funding size
Time since last funding
|6 years ago|
Keystone Heart investors
When was Keystone Heart founded?
Keystone Heart was founded in 2004.
Who are Keystone Heart key executives?
Keystone Heart's key executives are Pauliina Margolis.
How many employees does Keystone Heart have?
Keystone Heart has 31 employees.
Who are Keystone Heart competitors?
Competitors of Keystone Heart include Smith & Nephew, Liberator Medical Supply and Medequip.
Where is Keystone Heart headquarters?
Keystone Heart headquarters is located at Khalamish St 15, Caesarea.
Where are Keystone Heart offices?
Keystone Heart has offices in Caesarea and Tampa.
How many offices does Keystone Heart have?
Keystone Heart has 2 offices.
Receive alerts for 300+ data fields across thousands of companies